Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep;65(9):1969-1974.
doi: 10.1111/jgs.14956. Epub 2017 Jun 7.

Proton Pump Inhibitors and Risk of Mild Cognitive Impairment and Dementia

Felicia C Goldstein  1 , Kyle Steenland  2 , Liping Zhao  3 , Whitney Wharton  1 , Allan I Levey  1 , Ihab Hajjar  1   4
Affiliations

Proton Pump Inhibitors and Risk of Mild Cognitive Impairment and Dementia

Felicia C Goldstein et al. J Am Geriatr Soc. 2017 Sep.

Abstract

Objectives: To examine the risk associated with the use of proton pump inhibitors (PPIs) of conversion to mild cognitive impairment (MCI), dementia, and specifically Alzheimer's disease (AD).

Design: Observational, longitudinal study.

Setting: Tertiary academic Alzheimer's Disease Centers funded by the National Institute on Aging.

Participants: Research volunteers aged 50 and older with two to six annual visits; 884 were taking PPIs at every visit, 1,925 took PPIs intermittently, and 7,677 never reported taking PPIs. All had baseline normal cognition or MCI.

Measurements: Multivariable Cox regression analyses evaluated the association between PPI use and annual conversion of baseline normal cognition to MCI or dementia or annual conversion of baseline MCI to dementia, controlling for demographic characteristics, vascular comorbidities, mood, and use of anticholinergics and histamine-2 receptor antagonists.

Results: Continuous (always vs never) PPI use was associated with lower risk of decline in cognitive function (hazard ratio (HR) = 0.78, 95% confidence interval (CI) =0.66-0.93, P = .005) and lower risk of conversion to MCI or AD (HR = 0.82, 95% CI = 0.69-0.98, P = .03). Intermittent use was also associated with lower risk of decline in cognitive function (HR = 0.84, 95% CI = 0.76-0.93, P = .001) and risk of conversion to MCI or AD (HR = 0.82, 95% CI = 0.74-0.91, P = .001). This lower risk was found for persons with normal cognition or MCI.

Conclusion: Proton pump inhibitors were not associated with greater risk of dementia or of AD, in contrast to recent reports. Study limitations include reliance on self-reported PPI use and lack of dispensing data. Prospective studies are needed to confirm these results to guide empirically based clinical treatment recommendations.

Keywords: Alzheimer's disease; cognitive functioning; mild cognitive impairment; proton pump inhibitors.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: The authors have no disclosures.

Figures

Figure 1
Figure 1
Inclusion/Exclusion Criteria
Figure 2
Figure 2
Adjusted Survival Curves of Decline in Baseline Cognition to Mild Cognitive Impairment (MCI) or Dementia (Panel A) and Decline in Baseline Cognition to MCI or Dementia Due to Suspected AD (Panel B)
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Gomm W, Von Holt K, Thome F, et al. Association of proton pump inhibitors with risk of dementia: A pharmacoepidemiological claims data analysis. JAMA Neurology. 2016;73(4):410–416. - PubMed
    1. Haenisch B, von Holt K, Wiese B, et al. Risk of dementia in elderly patients with the use of proton pump inhibitors. European Archives of Psychiatry and Clinical Neuroscience. 2015;265:419–428. - PubMed
    1. Zaudig M, Hiller W. SIDAM – Strukturiertes Interview für die Diagnose einer Demenz vom Alzheimer Typ, der Multi-Infarkt-(oder vaskulären) Demenz und Demenzen anderer Ätiologie nach DSM-III-R, DSM-IV und ICD-10 (SIDAM-Handbuch) Huber, Bern. 1996
    1. Kuller LH. Do proton pump inhibitors increase the risk of dementia? JAMA Neurology. 2016;73(4):379–381. - PubMed
    1. Booker A, Jacob LE, Rapp M, Bohlken J, Kostev K. Risk factors for dementia diagnosis in German primary care practices. International Psychogeriatrics. 2016;28(7):1059–1065. - PubMed

Substances